NEW YORK (GenomeWeb News) – Roche Diagnostics said today that it has granted a non-exclusive license of its melting curve analysis technology to Agilent Technologies
Under the agreement, Agilent has acquired the rights to use, develop, and sell products that are based on Roche’s melting curve analysis technique, which is used in analyzing DNA in the PCR process.
After PCR, the resulting PCR product is slowly heated. Because each double-stranded DNA has its own specific melting temperature — defined as the temperature at which 50 percent of the DNA becomes single-stranded — the DNA can be identified by measuring the melting temperature, Roche said.
Financial terms of the agreement were not released.